Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-07 4:00 pm Sale | 2025-03-31 | 13G | COMPASS Pathways plc CMPS | Integrated Core Strategies (US) LLC | 2,773,521 3.000% | -639,927 (-18.75%) | Filing History |
| 2025-05-06 4:17 pm Sale | 2025-03-31 | 13G | Pyxis Oncology, Inc. PYXS | Integrated Core Strategies (US) LLC | 2,488,079 4.000% | -672,060 (-21.27%) | Filing History |
| 2025-05-02 4:00 pm Sale | 2025-03-31 | 13G | Golar LNG Limited GLNG | Integrated Core Strategies (US) LLC | 55,889 0.100% | -5,437,864 (-98.98%) | Filing History |
| 2025-05-01 4:13 pm Sale | 2025-03-31 | 13G | Abeona Therapeutics Inc. ABEO | Integrated Core Strategies (US) LLC | 809,966 1.700% | -1,491,662 (-64.81%) | Filing History |
| 2025-04-30 4:00 pm Sale | 2025-03-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Integrated Core Strategies (US) LLC | 322,082 0.600% | -2,456,443 (-88.41%) | Filing History |
| 2025-04-28 4:03 pm Purchase | 2025-04-22 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Integrated Core Strategies (US) LLC | 1,933,379 5.800% | 1,933,379 (New Position) | Filing History |
| 2025-04-25 4:05 pm Sale | 2025-03-31 | 13G | PHINIA Inc. PHIN | Integrated Core Strategies (US) LLC | 200,506 0.500% | -2,072,336 (-91.18%) | Filing History |
| 2025-04-24 4:02 pm Sale | 2025-03-31 | 13G | Cumberland Pharmaceuticals Inc. CPIX | Integrated Core Strategies (US) LLC | 809,897 5.800% | -419,736 (-34.14%) | Filing History |
| 2025-04-22 4:00 pm Sale | 2025-03-31 | 13G | Granite Construction Incorporated GVA | Integrated Core Strategies (US) LLC | 1,283,009 3.000% | -1,051,660 (-45.05%) | Filing History |
| 2025-03-18 4:00 pm Purchase | 2025-03-13 | 13G | NeoGenomics, Inc. NEO | Integrated Core Strategies (US) LLC | 6,954,120 5.400% | 6,954,120 (New Position) | Filing History |
| 2025-02-28 4:25 pm Purchase | 2025-02-25 | 13G | Golar LNG Limited GLNG | Integrated Core Strategies (US) LLC | 5,493,753 5.300% | 5,493,753 (New Position) | Filing History |
| 2025-02-11 4:01 pm Purchase | 2025-02-06 | 13G | UWM Holdings Corporation UWMC | Integrated Core Strategies (US) LLC | 10,558,347 6.700% | 10,245,670 (+3276.76%) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2025-02-05 | 13G | Cumberland Pharmaceuticals Inc. CPIX | Integrated Core Strategies (US) LLC | 1,229,633 8.800% | 1,229,633 (New Position) | Filing History |
| 2025-02-10 4:08 pm Sale | 2024-12-31 | 13G | Acelyrin, Inc. SLRN | Integrated Core Strategies (US) LLC | 4,714,402 4.700% | -431,027 (-8.38%) | Filing History |
| 2025-02-06 4:07 pm Sale | 2024-12-31 | 13G | COMPASS Pathways plc CMPS | Integrated Core Strategies (US) LLC | 3,413,448 3.700% | -473,753 (-12.19%) | Filing History |
| 2025-01-30 4:00 pm Sale | 2024-12-31 | 13G | Accolade, Inc. ACCD | Integrated Core Strategies (US) LLC | 3,090,861 3.800% | -999,481 (-24.44%) | Filing History |
| 2025-01-28 4:00 pm Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 1,994,503 3.500% | -954,373 (-32.36%) | Filing History |
| 2025-01-27 4:00 pm Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 6,292,634 4.300% | -3,107,939 (-33.06%) | Filing History |
| 2025-01-22 4:01 pm Purchase | 2025-01-14 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Integrated Core Strategies (US) LLC | 1,382,273 6.500% | 1,382,273 (New Position) | Filing History |
| 2024-12-16 4:04 pm Purchase | 2024-12-09 | 13G | Pyxis Oncology, Inc. PYXS | Integrated Core Strategies (US) LLC | 3,160,139 5.300% | 3,160,139 (New Position) | Filing History |